These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 1675216

  • 1. Alpha 1-adrenoceptor blockade and/or 5-HT1A agonism during treadmill exercise in dogs.
    Grohs JG, Fischer G, Huber S, Raberger G.
    J Auton Pharmacol; 1991 Apr; 11(2):101-7. PubMed ID: 1675216
    [Abstract] [Full Text] [Related]

  • 2. Influence of alpha 1-adrenoceptor blockade and/or 5-HT1A agonism on blood pressure and heart rate at rest and during exercise in hypertensive dogs.
    Grohs JG, Huber S, Fischer G, Raberger G.
    J Auton Pharmacol; 1992 Jun; 12(3):157-64. PubMed ID: 1352778
    [Abstract] [Full Text] [Related]

  • 3. Differential cardiovascular effects of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT), flesinoxan, 5-methyl-urapidil and MDL 75,608A in conscious spontaneously hypertensive rats.
    Buisson-Defferier S, Hibert M, van den Buuse M.
    Fundam Clin Pharmacol; 1993 Jun; 7(9):499-511. PubMed ID: 7906241
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Involvement of 5-HT1A receptors in blood pressure reduction by 8-OH-DPAT and urapidil in cats.
    Sanders KH, Beller KD, Kolassa N.
    J Cardiovasc Pharmacol; 1990 Jun; 15 Suppl 7():S86-93. PubMed ID: 1702492
    [Abstract] [Full Text] [Related]

  • 10. Systemic and regional hemodynamic effects of the putative 5-HT1A receptor agonist flesinoxan in the cat.
    Dreteler GH, Wouters W, Saxena PR.
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):770-6. PubMed ID: 2481192
    [Abstract] [Full Text] [Related]

  • 11. Central 5-HT1A receptors and the mechanism of the central hypotensive effect of (+)8-OH-DPAT, DP-5-CT, R28935, and urapidil.
    Doods HN, Boddeke HW, Kalkman HO, Hoyer D, Mathy MJ, van Zwieten PA.
    J Cardiovasc Pharmacol; 1988 Apr; 11(4):432-7. PubMed ID: 2453746
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Urapidil analogues are potent ligands of the 5-HT1A receptor.
    Gross G, Schüttler K, Xin X, Hanft G.
    J Cardiovasc Pharmacol; 1990 Apr; 15 Suppl 7():S8-16. PubMed ID: 1702491
    [Abstract] [Full Text] [Related]

  • 14. Contractile effects of 8-hydroxy-2-(di-n-propylamino)tetralin and flesinoxan in human isolated basilar artery.
    Parsons AA, Motevalian M, Whalley ET.
    Eur J Pharmacol; 1991 Sep 04; 202(1):17-23. PubMed ID: 1664803
    [Abstract] [Full Text] [Related]

  • 15. Systemic and regional hemodynamic effects of the 5-hydroxytryptamine1A receptor agonists flesinoxan and 8-hydroxy-2(di-N-propylamino)tetralin in the conscious rat.
    Dreteler GH, Wouters W, Toorop GP, Jansen JA, Saxena PR.
    J Cardiovasc Pharmacol; 1991 Mar 04; 17(3):488-93. PubMed ID: 1711612
    [Abstract] [Full Text] [Related]

  • 16. Hypotensive effects of 5-HT1A receptor agonists on the ventrolateral medullary pressor area in dogs.
    Dabiré H, Laubie M, Schmitt H.
    J Cardiovasc Pharmacol; 1990 Mar 04; 15 Suppl 7():S61-7. PubMed ID: 1702488
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Influence of urapidil and 8-OH-DPAT on brain 5-HT turnover and blood pressure in rats.
    Valenta B, Kotai E, Weisz E, Singer EA.
    J Cardiovasc Pharmacol; 1990 Mar 04; 15 Suppl 7():S68-74. PubMed ID: 1702489
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.